- Report
- May 2022
- 37 Pages
Global
From €1790EUR$2,000USD£1,525GBP
Aspergillosis is a type of fungal infection caused by the Aspergillus fungus. It can affect the lungs, sinuses, and other organs. Treatment for aspergillosis typically involves antifungal medications. The Aspergillosis Drug market is a subset of the larger Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. Aspergillosis drugs are used to treat a variety of forms of the infection, including allergic bronchopulmonary aspergillosis, chronic pulmonary aspergillosis, and invasive aspergillosis. These drugs are typically administered orally or intravenously.
Some companies in the Aspergillosis Drug market include Merck & Co., Pfizer, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more